These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25976242)

  • 1. GCKR polymorphism influences liver fat content in patients with type 2 diabetes.
    Petit JM; Masson D; Guiu B; Rollot F; Duvillard L; Bouillet B; Brindisi MC; Buffier P; Hillon P; Cercueil JP; Verges B
    Acta Diabetol; 2016 Apr; 53(2):237-42. PubMed ID: 25976242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of
    Nisar T; Arshad K; Abbas Z; Khan MA; Safdar S; Shaikh RS; Saeed A
    J Obes; 2023; 2023():6661858. PubMed ID: 37829557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes.
    Petit JM; Guiu B; Masson D; Duvillard L; Jooste V; Buffier P; Bouillet B; Brindisi MC; Robin I; Gambert P; Verges B; Cercueil JP; Hillon P
    Liver Int; 2011 Oct; 31(9):1332-6. PubMed ID: 21745307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of Rs780094 and Rs1260326 Polymorphisms in GCKR Gene to Non-alcoholic Fatty Liver Disease: A Meta-Analysis Involving 26,552 Participants.
    Li J; Zhao Y; Zhang H; Hua W; Jiao W; Du X; Rui J; Li S; Teng H; Shi B; Yang X; Zhu L
    Endocr Metab Immune Disord Drug Targets; 2021; 21(9):1696-1708. PubMed ID: 33243135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.
    Vaxillaire M; Cavalcanti-Proença C; Dechaume A; Tichet J; Marre M; Balkau B; Froguel P;
    Diabetes; 2008 Aug; 57(8):2253-7. PubMed ID: 18556336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglyceride response to an intensive lifestyle intervention is enhanced in carriers of the GCKR Pro446Leu polymorphism.
    Pollin TI; Jablonski KA; McAteer JB; Saxena R; Kathiresan S; Kahn SE; Goldberg RB; Altshuler D; Florez JC;
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1142-7. PubMed ID: 21525158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified response of NAFLD patients with non-significant fibrosis in nutritional counseling according to GCKR rs1260326.
    Kaliora AC; Kalafati IP; Gioxari A; Diolintzi A; Kokkinos A; Dedoussis GV
    Eur J Nutr; 2018 Sep; 57(6):2227-2235. PubMed ID: 28695325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GCKR and GCK polymorphisms are associated with increased risk of end-stage kidney disease in Chinese patients with type 2 diabetes: The Hong Kong Diabetes Register (1995-2019).
    Wang K; Shi M; Yang A; Fan B; Tam CHT; Lau E; Luk AOY; Kong APS; Ma RCW; Chan JCN; Chow E
    Diabetes Res Clin Pract; 2022 Nov; 193():110118. PubMed ID: 36243233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early gene-diet interaction between glucokinase regulatory protein (GCKR) polymorphism, vegetable and fish intakes in modulating triglyceride levels in healthy adolescents.
    Tam CH; Wang Y; Lee HM; Luk AO; Tong PC; Chan MH; Ozaki R; Kong AP; So WY; Chan JC; Ma RC
    Nutr Metab Cardiovasc Dis; 2015 Oct; 25(10):951-8. PubMed ID: 26234566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesity.
    Di Costanzo A; Pacifico L; Chiesa C; Perla FM; Ceci F; Angeloni A; D'Erasmo L; Di Martino M; Arca M
    Pediatr Res; 2019 Apr; 85(5):671-677. PubMed ID: 30710115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in the GCKR gene is associated with non-alcoholic fatty liver disease in Chinese people.
    Yang Z; Wen J; Tao X; Lu B; Du Y; Wang M; Wang X; Zhang W; Gong W; Ling C; Wu S; Hu R
    Mol Biol Rep; 2011 Feb; 38(2):1145-50. PubMed ID: 20625834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
    Varbo A; Benn M; Tybjærg-Hansen A; Grande P; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):451-7. PubMed ID: 21071687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specifically PNPLA3-mediated accumulation of liver fat in obese patients with type 2 diabetes.
    Petit JM; Guiu B; Masson D; Duvillard L; Jooste V; Buffier P; Terriat B; Bouillet B; Brindisi MC; Loffroy R; Robin I; Hillon P; Cercueil JP; Verges B
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E430-6. PubMed ID: 20826584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.
    Santoro N; Zhang CK; Zhao H; Pakstis AJ; Kim G; Kursawe R; Dykas DJ; Bale AE; Giannini C; Pierpont B; Shaw MM; Groop L; Caprio S
    Hepatology; 2012 Mar; 55(3):781-9. PubMed ID: 22105854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326.
    Ford BE; Chachra SS; Rodgers K; Moonira T; Al-Oanzi ZH; Anstee QM; Reeves HL; Schattenberg JM; Fairclough RJ; Smith DM; Tiniakos D; Agius L
    Mol Metab; 2023 Jun; 72():101722. PubMed ID: 37031802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional glucokinase regulator gene variants have inverse effects on triglyceride and glucose levels, and decrease the risk of obesity in children.
    Horvatovich K; Bokor S; Polgar N; Kisfali P; Hadarits F; Jaromi L; Csongei V; Repasy J; Molnar D; Melegh B
    Diabetes Metab; 2011 Nov; 37(5):432-9. PubMed ID: 21511510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of GCKR Gene Polymorphisms with the Risk of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease in a Chinese Northern Han Population.
    Gao H; Liu S; Zhao Z; Yu X; Liu Q; Xin Y; Xuan S
    J Clin Transl Hepatol; 2019 Dec; 7(4):297-303. PubMed ID: 31915598
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification and characterization of a FOXA2-regulated transcriptional enhancer at a type 2 diabetes intronic locus that controls GCKR expression in liver cells.
    López Rodríguez M; Kaminska D; Lappalainen K; Pihlajamäki J; Kaikkonen MU; Laakso M
    Genome Med; 2017 Jul; 9(1):63. PubMed ID: 28683826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of common polymorphisms in GCKR with type 2 diabetes and related traits in a Han Chinese population: a case-control study.
    Ling Y; Li X; Gu Q; Chen H; Lu D; Gao X
    BMC Med Genet; 2011 May; 12():66. PubMed ID: 21569451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variability of GCKR alters lipid profiles in children with monogenic and autoimmune diabetes.
    Tracz A; Madzio J; Gnys P; Malachowska B; Borowiec M; Wyka K; Jarosz-Chobot P; Mysliwiec M; Szadkowska A; Mlynarski W; Fendler W;
    Exp Clin Endocrinol Diabetes; 2014 Oct; 122(9):503-9. PubMed ID: 24918535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.